ARCHIVES

J&J Withdraws Power Morcellators, Citing Risk of Disseminating Cancer

This article is from The Cancer Letter archive.

Vol. 40 No. 31 | August 1, 2014

Download PDF Visit The Full Archive

Related Articles

Grants Funding; NCI Restores Paylines To Last Year’s Levels

July 4, 1997

Dendritic Cell Vaccine May Boost Median Survival

March 25, 2011

Clinical Trials Approved By NCI Last Month Listed

February 22, 2002

Ten Cooperative Group Chairs Propose Eight “Guiding Principles” For Change

May 20, 2011

FDA Approves Two Oral Drugs For Metastatic Melanoma

June 28, 2013

Clinton Endorses Legislation Preventing Genetic Discrimination

May 23, 1997